T49.4X
Poisoning by, adverse effect of and underdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code T49.4X refers to poisoning, adverse effects, or underdosing related to keratolytics, keratoplastics, and other hair treatment medications. These products are commonly used for hair care and scalp treatments. While generally safe when used correctly, misuse or accidental overdose can lead to adverse health effects. Recognizing the associated risks and symptoms is essential for ensuring safe use and prompt management of possible reactions.
Causes & Symptoms
Clinical Causes: Accidental ingestion of hair treatment products containing keratolytics or keratoplastics. Incorrect application or overuse of topical hair medications. Use of expired or improperly stored products leading to unintended effects. Self-medication without professional guidance, resulting in overdose or adverse reactions. Sensitivities or allergies to specific ingredients within hair treatment drugs.
Key Symptoms: Skin irritation, redness, or itching at the application site. Burning sensation or dermatitis on the scalp or surrounding skin. Systemic symptoms such as nausea, vomiting, or dizziness if the substance is ingested or absorbed in significant amounts. Respiratory issues like coughing or difficulty breathing if inhaled fumes are irritating. Signs of allergic reaction, including swelling of the face, lips, or tongue, or difficulty swallowing.
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a thorough patient history, including recent hair treatment activities and product use. Physical examination assesses skin reactions and systemic symptoms. Laboratory tests may be conducted to identify any toxic substances in the blood if ingestion is suspected. The healthcare provider also evaluates for allergic reactions or other related complications. Identification of the specific product used can aid in targeted treatment strategies.
Treatment Protocols: Removing the affected product from the skin or scalp to minimize further irritation. Washing the skin with gentle cleansers to reduce chemical contact. Administration of medications to counteract allergic reactions, such as antihistamines or corticosteroids. Providing supportive care for systemic symptoms, including intravenous fluids or medications for nausea and dizziness. In cases of ingestion, activated charcoal may be used if appropriate and within a certain timeframe. Monitoring in a medical facility if severe symptoms or systemic toxicity are present.
Clinical Advice & FAQs
Billing Guidance
Is T49.4X a billable ICD-10 code?
Yes, T49.4X is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T49.4X?
Clinical documentation must specify the nature of Poisoning by, adverse effect of and underdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
